Overview

A Study of E6005 in Japanese Patients With Atopic Dermatitis

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The safety and pharmacokinetics of topical application with E6005 ointment compared to vehicle will be evaluated in Japanese male patients with atopic dermatitis. Additionally, the efficacy of topical application with E6005 ointment will be explored in Japanese male patients with atopic dermatitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Dermavant Sciences GmbH
Eisai Co., Ltd.